| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 139.514 | 418.460 | 238.468 | 2.378 | 0 |
| Total Income - EUR | - | - | - | - | 0 | 139.582 | 419.168 | 238.552 | 2.379 | 0 |
| Total Expenses - EUR | - | - | - | - | 0 | 80.763 | 194.692 | 76.134 | 43.848 | 16.271 |
| Gross Profit/Loss - EUR | - | - | - | - | 0 | 58.819 | 224.476 | 162.419 | -41.470 | -16.271 |
| Net Profit/Loss - EUR | - | - | - | - | 0 | 57.501 | 220.790 | 160.555 | -41.493 | -16.271 |
| Employees | - | - | - | - | 0 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Yasvit Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 85 | 5.235 | 6.155 | 1.677 | 217 | 0 |
| Current Assets | - | - | - | - | 432 | 55.627 | 234.983 | 430.660 | 426.145 | 338.351 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 1.206 | 1.202 | 0 |
| Receivables | - | - | - | - | 0 | 23.018 | 157.478 | 347.179 | 410.428 | 338.351 |
| Cash | - | - | - | - | 432 | 32.608 | 77.505 | 82.276 | 14.515 | 0 |
| Shareholders Funds | - | - | - | - | 421 | 57.915 | 235.311 | 382.501 | 339.386 | 257.631 |
| Social Capital | - | - | - | - | 421 | 413 | 404 | 406 | 404 | 402 |
| Debts | - | - | - | - | 95 | 2.947 | 5.827 | 49.836 | 86.976 | 80.719 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
1089
|
|||||||||
Comments - Yasvit Pharma S.r.l.